All Research
    PAPER TG-HDLSystematic Review2024

    The Triglyceride/HDL Ratio as a Surrogate Biomarker for Insulin Resistance

    Review of 32 studies (nearly 50,000 participants) evaluating the TG/HDL ratio as a low-cost surrogate marker of insulin resistance across populations.

    Evidence

    —

    Not Rated

    Sample

    —

    subjects

    Duration

    —

    study period

    Journal

    Biomedicines

    Jul 2024

    03

    Structured Methods

    Study Design
    Systematic Review
    Sample Size
    Not reported
    Study Duration
    Not reported
    Methodology
    Not reported
    Limitations
    Not reported
    04

    Citations & References

    Cite this paper

    Unknown authors (2024). The Triglyceride/HDL Ratio as a Surrogate Biomarker for Insulin Resistance. Biomedicines. https://doi.org/10.3390/biomedicines12071493

    05

    Indexing

    Biomarkers

    tg-hdl-ratio
    PHS
    671
    / 1000
    T3
    Longevity Operator

    Sample member

    Longevity Operator

    The Peak Human Score · PHS v1

    One number for your longevity journey.

    FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.

    • Metabolic
    • Hormonal
    • Cardiovascular
    • Brain / Cognitive
    • Sleep
    • Musculoskeletal
    • Gut
    • Immunity / Inflammation